“abl”的搜索结果

产品 1 到 50 共 176个

每页
页面:
  1. 1
  2. 2
  3. 3
  4. 4

设置降序顺序
  1. CHMFL-ABL/KIT-155

    Catalog No. A12421
    Quick View
    ABL/c-KIT dual kinase inhibitor
    CHMFL-ABL/KIT-155 (CHMFL-ABL-KIT-155; compound 34) is a highly potent and orally active type II ABL/c-KIT dual kinase inhibitor. 了解更多
  2. CHMFL-ABL-039

    Catalog No. A13182
    Quick View
    BCR-ABL inhibitor
    CHMFL-ABL-039 is a type II native ABL kinase and drug-resistant V299L mutant BCR-ABL inhibitor with the IC50s of 7.9 nM and 27.9 nM, respectively. CHMFL-ABL-039 is used in the research of chronic myeloid leukemia. 了解更多
  3. BCR-ABL-IN-1

    Catalog No. A12496
    Quick View
    BCR-ABL inhibitor
    BCR-ABL-IN-1 is an inhibitor of BCR-ABL tyrosine kinase, with a pIC50 of 6.46, and may be used in the research of chronic myelogenous leukemia. 了解更多
  4. SNIPER(ABL)-062

    Catalog No. A18567
    Quick View
    ABL inhibitor
    SNIPER(ABL)-062, in which an ABL inhibitor is linked to a ligand of cIAP1 via a linker containing a variable polyethylene glycol (PEG) unit, shows a potent activity to degrade the BCR-ABL protein. 了解更多
  5. CHMFL-ABL-121

    Catalog No. A19079
    Quick View
    ABL2 inhibitor
    CHMFL-ABL-121 is a highly potent type II ABL kinase inhibitor with IC50s of 2 nM and 0.2 nM against purified inactive ABL wt and T315I kinase protein, respectively. 了解更多
  6. BCR-ABL-IN-2

    Catalog No. A21043
    Quick View
    inhibitor of BCR-ABL1 tyrosine kinase
    BCR-ABL-IN-2 is an inhibitor of BCR-ABL1 tyrosine kinase, with IC50s of 57 nM, 773 nm for ABL1native and ABL1T315I, respectively. 了解更多
  7. KW-2449

    Catalog No. A10508
    Quick View
    FLT3/FGFR/Bcr-Abl/Aurora 抑制剂
    KW-2449是FLT3、ABl、ABl-T315I和Aurora激酶的多激酶抑制剂。 了解更多
  8. 1-Naphthyl PP1 hydrochloride

    Catalog No. A21790
    Quick View
    Src/c-Abl inhibitor
    1-Naphthyl PP1 hydrochloride is a selective inhibitor of src family kinases v-Src and c-Fyn as well as the tyrosine kinase c-Abl (IC50 values are 1.0, 0.6, 0.6, 18 and 22 μM for v-Src, c-Fyn, c-Abl, CDK2 and CAMK II respectively). 了解更多
  9. GZD824 Dimesylate

    Catalog No. A15849
    Quick View
    Bcr-Abl 抑制剂
    GZD824 Dimesylate是Bcr-Abl(WT)和Bcr-Abl(T315I)的新型生物可用Bcr-Abl抑制剂,IC50分别为0.34 nM和0.68 nM。 了解更多
  10. XL-228

    Catalog No. A13069
    Quick View
    IGF-1R, Aurora, FGFR, ABL, SRC 抑制剂
    XL228是靶向IGF1R,AURORA激酶,FGFR1-3,ABL和SRC家族激酶的蛋白激酶抑制剂。XL228是一种Aurora A抑制剂(IC50,f3 nmol/L),对ABL1(Ki,5 nmol/L)以及BCR-ABL1 T315I(Ki,1.4 nmol/L)激酶显示出有效的生化活性。 了解更多
  11. CZC-8004

    Catalog No. A19444
    Quick View
    ABL inhibitor
    CZC-8004 is a pan-kinase inhibitor and binds a range of tyrosine kinases, including ABL kinase. 了解更多
  12. Lyn-IN-1

    Catalog No. A16265
    Quick View
    dual Bcr-Abl/Lyn 抑制剂
    Lyn-IN-1是一种有效的选择性Bcr-Abl/Lyn双重抑制剂,摘自专利WO2014169128A1。 了解更多
  13. GNF-7

    Catalog No. A15887
    Quick View
    Bcr-Abl 抑制剂
    GNF-7是一种有效的II型激酶Bcr-Abl抑制剂,对于M351T,T315I,E255 V,G250E和c-Abl,IC50分别<5 nM,61 nM,122 nM,136 nM和133 nM。 了解更多
  14. AG 957

    Catalog No. A13589
    Quick View
    p210 tyrosine kinase 抑制剂
    AG 957是有效的酪氨酸激酶抑制剂。与p140c-abl(Ki = 10μM)相比,选择性阻断人p210bcr-abl(Ki = 750 nM)的酪氨酸激酶活性。 了解更多
  15. Dasatinib (BMS-354825)

    Catalog No. A10290
    Quick View
    Abl-Src 抑制剂
    Dasatinib (BMS-354825)是一种口服多BCR/ABL和Src家族酪氨酸激酶抑制剂。Dasatinib (BMS-354825)的主要靶标是BCR/ABL,Src,c-Kit,ephrin受体和其他几种酪氨酸激酶,但不是erbB激酶,例如EGFR或Her2。 了解更多
  16. Bafetinib (INNO-406)

    Catalog No. A10119
    Quick View
    Bcr-Abl 抑制剂
    Bafetinib (INNO-406)是一种双重Bcr-Abl/Lyn酪氨酸激酶抑制剂。 了解更多
  17. AP24534 (Ponatinib)

    Catalog No. A10080
    Quick View
    BCR-ABL 抑制剂
    AP24534 (Ponatinib)是有效的多激酶和pan-BCR-ABL抑制剂。 了解更多
  18. Mcl1-IN-9

    Catalog No. A18372
    Quick View
    Mcl-1 Inhibitor
    Mcl1-IN-9 is a potent myeloid cell leukemia-1 (Mcl-1) Inhibitor with an IC50 of 446 nM in reengineered BCR-ABL+ B-ALL cells and a Ki of 0.03 nM. 了解更多
  19. ON 146040

    Catalog No. A16266
    Quick View
    dual PI3K and BCR-ABL 抑制剂
    ON 146040是第一个靶向STAT3和STAT5途径的PI3K和BCR-ABL双重抑制剂;抑制PI3Kα/δ同工型,IC50为14/20 nM。 了解更多
  20. GZD824

    Catalog No. A16264
    Quick View
    Bcr-Abl 抑制剂
    GZD824是一种新型的口服生物利用型抑制剂,可抵抗包括T315I在内的各种Bcr-Abl突变体。 了解更多
  21. Flumatinib

    Catalog No. A16258
    Quick View
    multi-kinase 抑制剂
    Flumatinib是一种多激酶抑制剂,对c-Abl,PDGFRbeta和c-Kit的IC50值分别为1.2 nM,307.6 nM和2662 nM。 了解更多
  22. NVP-BAW2881

    Catalog No. A12693
    Quick View
    VEGFR 抑制剂
    NVP-BAW2881是有效的选择性VEGFR抑制剂(血管内皮生长因子受体酪氨酸激酶抑制剂),IC50 为值9 nM,具有抑制慢性和急性皮肤炎症的作用。 了解更多
  23. Radotinib (IY-5511)

    Catalog No. A13029
    Quick View
    Bcr-Abl tyrosine 抑制剂?
    Radotinib是一种新型的选择性Bcl-Abl酪氨酸激酶抑制剂。 了解更多
  24. Nilotinib monohydrochloride monohydrate

    Catalog No. A15186
    Quick View
    Bcr-Abl 抑制剂
    Nilotinib monohydrochloride monohydrate是一种Bcr-Abl抑制剂,IC50小于30 nM。 了解更多
  25. NRC-AN-019

    Catalog No. A13562
    Quick View
    Bcr-Abl 抑制剂
    NRC-AN-019是Bcr-Abl蛋白-酪氨酸激酶的口服酪氨酸激酶抑制剂(TKI)。NRC-AN-019在抑制MDAMB231和HTB20/BT474细胞的血管生成潜力和增殖方面更有效。 了解更多
  26. Flumatinib mesylate

    Catalog No. A13530
    Quick View
    c-Abl/c-Kit/PDGRFβ 抑制剂
    Flumatinib mesylate以时间和剂量依赖性的方式降低U266细胞中C-MYC,HIF-1a和VEGF的表达,因此甲磺酸氟马替尼可能成为MM治疗的新药。 了解更多
  27. GNF-5

    Catalog No. A13237
    Quick View
    Bcr-Abl 抑制剂
    GNF-5是BCR-ABL的选择性变构抑制剂。 了解更多
  28. PD173955

    Catalog No. A13120
    Quick View
    Bcr-Abl 抑制剂
    PD-173955是src酪氨酸激酶抑制剂。PD173955抑制Bcr-Abl依赖的细胞生长。PD173955显示G(1)中的细胞周期停滞。PD173955在Bcr-Abl的激酶抑制测定中的IC(50)为1-2 nM,在细胞生长测定中,其抑制Bcr-Abl依赖性底物酪氨酸磷酸化。 PD173955抑制试剂盒配体依赖性c-kit自磷酸化(IC(50)=约25 nM)和试剂盒配体依赖性M07e细胞增殖(IC(50)= 40 nM),但对白介素3依赖性(IC (50)= 250 nM)或粒细胞巨噬细胞集落刺激因子(IC(50)= 1 microM)依赖性细胞生长。 了解更多
  29. PP1

    Catalog No. A12724
    Quick View
    Src 抑制剂
    PP1是Src家族酪氨酸激酶的有效抑制剂。抑制p56lck和p59fynT(IC50值分别为5和6 nM)。在ZAP-70和JAK2上显示的选择性> 8000倍。还适度抑制p38,CSK,PDGF受体,RET衍生的癌蛋白,c-Kit和Bcr-Abl。 了解更多
  30. GNF 2

    Catalog No. A11439
    Quick View
    Bcr-Abl 抑制剂
    GNF 2是一种Bcr-abl抑制剂,在表达Bcr-abl的细胞中抑制增殖并诱导凋亡。 了解更多
  31. Nilotinib (AMN-107)

    Catalog No. A10644
    Quick View
    Bcr-Abl 抑制剂
    Nilotinib (AMN-107)是一种Bcr-Abl抑制剂,IC50小于30 nM。 了解更多
  32. DCC-2036 (Rebastinib)

    Catalog No. A11200
    Quick View
    Bcr-Abl 抑制剂
    DCC-2036 (Rebastinib)是一种Bcr-Abl抑制剂,作用于Abl1(WT)和Abl1(T315I),IC50分别为0.8 nM和4 nM,也抑制SRC, LYN, FGR, HCK, KDR, FLT3,和Tie-2,对c-Kit具有低的抑制活性。 了解更多
  33. NVP-BHG712

    Catalog No. A10661
    Quick View
    EphB4 抑制剂
    NVP-BHG712是EphB4激酶的选择性抑制剂,在体外对EphB4的选择性超过40多种其他激酶(包括FGFR3)。 了解更多
  34. Imatinib Mesylate

    Catalog No. A10468
    Quick View
    Bcr-Abl 抑制剂
    Imatinib mesylate是一种选择性酪氨酸激酶抑制剂,通过抑制KIT信号转导途径,在治疗胃肠间质瘤中诱导了持续的客观反应。 了解更多
  35. Danusertib (PHA-739358)

    Catalog No. A10715
    Quick View
    Aurora 抑制剂
    Danusertib (PHA-739358)是Aurora A/B/C的Aurora激酶抑制剂,在无细胞分析中的IC50为13 nM/79nM/61 nM,对Abl,TrkA,c-RET和FGFR1以及更低的浓度具有中等效力 对Lck,VEGFR2/3,c-Kit,CDK2等有效。 了解更多
  36. WP1130 (Degrasyn)

    Catalog No. A10988
    Quick View
    DUB/Bcr/ABL 抑制剂
    WP1130 (Degrasyn)是一种新型的选择性小分子去泛素酶抑制剂和Bcr/Abl破坏途径激活剂,可特异性和快速下调野生型和突变型Bcr/Abl蛋白,而不会影响慢性粒细胞性白血病(CML)中的bcr/abl基因表达细胞。 了解更多
  37. Saracatinib (AZD0530)

    Catalog No. A10108
    Quick View
    Src/Abl 抑制剂
    Saracatinib (AZD0530)是一种高选择性,双特异性Src/Abl激酶抑制剂,对c-Src和Abl激酶的IC50分别为2.7和30 nM。 了解更多
  38. Imatinib (Gleevec)

    Catalog No. A10259
    Quick View
    PDGFR 抑制剂
    Imatinib (Gleevec)是一种多靶点酪氨酸激酶抑制剂,抑制v-Abl、c-Kit和PDGFR的IC50分别为0.6,0.1和0.1 μM。 了解更多
    • 最新产品

    AMG-510 (Sotorasib)

    Catalog No. A19021
    Quick View
    KRAS G12C covalent inhibitor
    AMG-510 is a potent, orally bioavailable, and selective KRAS G12C covalent inhibitor with anti-tumor activity. 了解更多
  39. 2-APB

    Catalog No. A18088
    Quick View
    IP3R inhibitor
    2-Aminoethyl diphenylborinate (2-APB) is a cell-permeable inhibitor of IP3R. 2-Aminoethyl diphenylborinate also inhibits the store-operated Ca2+ (SOC) channel and activates some TRP channels (V1, V2 and V3). 了解更多
  40. TAK-659

    Catalog No. A20450
    Quick View
    SYK/FLT3 inhibitor
    TAK-659 is a highly potent, selective, reversible and orally available dual inhibitor of spleen tyrosine kinase (SYK) and fms related tyrosine kinase 3 (FLT3), with an IC50 of 3.2 nM and 4.6 nM for SYK and FLT3, respectively. 了解更多
  41. Upamostat

    Catalog No. A21035
    Quick View
    serine protease inhibitor
    Upamostat is a serine protease inhibitor. Upamostat is the orally available prodrug of the WX-UK1, which is a urokinase plasminogen activator (uPA) inhibitor. 了解更多
  42. Tirabrutinib

    Catalog No. A21019
    Quick View
    BTK inhibitor
    Tirabrutinib (ONO-4059) is a highly selective, orally bioavailable BTK inhibitor with an IC50 of 2.2 nM. 了解更多
  43. NMS-P118

    Catalog No. A20994
    Quick View
    PARP-1 Inhibitor
    NMS-P118 is a potent, orally available, and highly selective PARP-1 Inhibitor for cancer therapy. 了解更多
  44. TAS-116

    Catalog No. A20987
    Quick View
    HSP90??/HSP90?? inhibitor
    TAS-116 is an oral bioavailable, ATP-competitive, highly specific HSP90α/HSP90β inhibitor (Kis of 34.7 nM and 21.3 nM, respectively) without inhibiting other HSP90 family proteins such as GRP94. TAS-116 demonstrates less ocular toxicity. 了解更多
  45. MI-503

    Catalog No. A20975
    Quick View
    menin-mLL interaction inhibitor
    MI-503 is a highly potent and orally bioavailable small molecule inhibitor of the menin-mLL interaction. 了解更多
  46. CK-666

    Catalog No. A20973
    Quick View
    Arp2/3 complex inhibitor
    CK-666 is a cell-permeable inhibitor of actin-related protein Arp2/3 complex, and binds to Arp2/3 complex, stabilizes the inactive state of the complex, blocking movement of the Arp2 and Arp3 subunits into the activated filament-like (short pitch) conformation. 了解更多
  47. MF-438

    Catalog No. A20963
    Quick View
    SCD1 inhibitor
    MF-438 is a potent and orally bioavailable stearoyl-CoA desaturase 1 (SCD1) inhibitor with an EC50 of 2.3 nM for rSCD1. 了解更多
  48. SEL120-34A HCl

    Catalog No. A21485
    Quick View
    CDK8 inhibitor
    SEL120-34A HCl is a potent, selective, orally available, ATP-competitive CDK8 inhibitor, with IC50s of 4.4 nM and 10.4 nM for CDK8/CycC and CDK19/CycC, respectively, with antitumor activity. 了解更多
  49. Carotegrast

    Catalog No. A21997
    α4 integrin receptor inhibitor
    Carotegrast is an orally available α4 integrin receptor inhibitor with anti-inflammatories activities. 了解更多

产品 1 到 50 共 176个

每页
页面:
  1. 1
  2. 2
  3. 3
  4. 4

设置降序顺序
Rewards